UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Catabasis Pharmaceuticals is implementing good security practices.
Catabasis Pharmaceuticals, founded in 2008 and based in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company. Catabasis’ SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables the company to engineer molecules that simultaneously modulate multiple targets in a disease.
This report shows a preliminary security rating for Catabasis Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Every week the news is full of new exposures of protected health information (PHI) and personally ...
According to the 2019 Cost of Data Breach Report from Ponemon Institute and IBM Security, the ...
Compare Catabasis Pharmaceuticals's security performance with other companies